Elazzouzi Amy, Senior Vice President of Finance at Aura Biosciences, Inc. ($AURA), sold shares on the open market five times over the past year, totaling about $113 thousand. Her most recent sale occurred on February 17, 2026. These transactions rank her 9,387th out of 11,678 insiders by sale value, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | A | Stock Option (Right to Buy) | 80472 | $0.00 | 80,472.0000 | 65,936,672 | 9999.99% | 0.12% |
| March 2, 2026 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | A | Common Stock | 44528 | $0.00 | 120,060.0000 | 65,936,672 | 58.95% | 0.07% |
| Feb. 17, 2026 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 8549 | $5.06 | 75,532.0000 | 65,936,672 | 10.17% | 0.01% |
| Jan. 20, 2026 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 1581 | $4.86 | 84,081.0000 | 65,936,672 | 1.85% | 0.00% |
| Oct. 29, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 896 | $6.35 | 85,662.0000 | 65,936,672 | 1.04% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 1094 | $3.16 | 91,961.0000 | 49,650,480 | 1.20% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 2319 | $4.25 | 94,280.0000 | 49,650,480 | 2.52% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 7722 | $6.70 | 86,558.0000 | 49,650,480 | 8.19% | 0.02% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 2554 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.01% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 1094 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 547 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 547 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 4744 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.01% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 2554 | $5.07 | 83,935.0000 | 49,650,480 | 3.14% | 0.01% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 2319 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 1094 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 1094 | $5.48 | 85,029.0000 | 49,650,480 | 1.30% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 547 | $5.48 | 85,576.0000 | 49,650,480 | 0.64% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 547 | $5.21 | 86,123.0000 | 49,650,480 | 0.64% | 0.00% |
| Aug. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 4744 | $2.74 | 90,867.0000 | 49,650,480 | 5.51% | 0.01% |
| April 16, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 897 | $5.49 | 81,381.0000 | 49,650,480 | 1.09% | 0.00% |
| Feb. 18, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 1404 | $7.75 | 82,278.0000 | 49,650,480 | 1.68% | 0.00% |
| Feb. 3, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | A | Stock Option (Right to Buy) | 29760 | $0.00 | 29,760.0000 | 49,650,480 | 9999.99% | 0.06% |
| Feb. 3, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Senior Vice President, Finance | A | Common Stock | 45240 | $0.00 | 83,682.0000 | 49,650,480 | 117.68% | 0.09% |
| Jan. 21, 2025 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Vice President, Finance | S | Common Stock | 1001 | $7.67 | 38,442.0000 | 49,650,480 | 2.54% | 0.00% |
| Oct. 29, 2024 | Aura Biosciences, Inc. | $AURA | Elazzouzi Amy | Vice President, Finance | S | Common Stock | 553 | $10.74 | 39,443.0000 | 49,663,532 | 1.38% | 0.00% |